Bio-Techne Corporation today announced that Asuragen, a Bio-Techne brand, has teamed up with Oxford Nanopore Technologies to launch the AmplideX® Nanopore Carrier Plus Kit, a new genetic panel and supporting analysis software for carrier screening research.
View the Full Press ReleaseAsuragen will showcase the new assay at the upcoming San Antonio Breast Cancer Symposium beginning on December 10th, 2024
View the Full Press ReleaseThe QuantideX® qPCR BCR-ABL IS Kit is now compliant with the latest diagnostic regulations in Europe
Learn more about the new IVDR certificationBio-Techne and Asuragen are proud to share that Dr. Jordan Laser received the AMP Meritorious Service Award this year to recognize his work behind the scenes to position AMP as the premier molecular diagnostics professional association around the world. Dr. Laser serves as Senior Director, Clinical and Medical Affairs, for Bio-Techne's Diagnostics and Genomics Segment.
See the full Press ReleaseLearn more about Asuragen's operations in EMEA to get an insight into how we provide solutions to our European customers who are employing diagnostics in the fields of genetics and oncology.
Learn more about our Genetics and Oncology Diagnostics Kits for the EMEA MarketThe AmplideX® TRIO Workflow brings simplicity and scalability to FMR1, SMN1/2, and CFTR analysis and is optimized for use on widely established laboratory equipment. Easy to use Reporter Software included!
Streamline your Workflow TodayThe AmplideX® PCR/CE HTT Kit is a simple, robust, and reliable test for the detection of CAG trinucleotide repeats within the HTT gene, aberrations which are associated with the development of Huntington’s Disease (HD).
Read more about our HTT kitAsuragen, Inc has developed an Armored RNA Quant® SARS-CoV-2 Control for use in developing assays in response to the COVID-19 pandemic.
Learn more about our Armored RNA Quant SARS-CoV-2 Control
Prof. Anne-Sophie from the University of Reims Champagne-Ardenne in France, guides us through the story of meeting the Asuragen team and her contribution to the development of the AmplideX® Nanopore Carrier Plus kit, launching later this year.